Latest News
I love writing guest articles and collaborating
See appearances for Asa's events and podcasts
Jan 31, 2023
Interview
Steven Hoffman
Hemp and CBD Industry Responds to FDA’s Announcement on CBD
Asa and other industry leaders interviewed
Jan 24, 2023
Interview
Jennifer Grebow
Is FDA watching heart health supplements in 2023? 2023 Ingredient trends for food, drinks, dietary supplements, and natural products
Asa and other industry leaders interviewed
Jan 20, 2023
Contributing Author
Let's Talk Hemp
FDA Warning Letters, activity and actions in 2022 and what that means for 2023
Hemp Industry 2023 Opportunities Report
Jan 18, 2023
Interview
Palmate, LLC
Why CBD Companies Should Re-Examine Their Marketing Content -- NOW
Jan 17, 2023
Interview
Danielle Masterson
House Oversight chair to FDA: Enough is enough
Asa and other industry leaders interviewed
Dec 20, 2022
Guest Article
Asa Waldstein
Q4 warning letter roundup with Asa Waldstein
In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.
Nov 23, 2022
Interview
Judy Blatman
Stay in your lane: Novel delivery systems must comply with supplement regulations
Asa and other industry leaders interviewed
Nov 17, 2022
Guest Article
Asa Waldstein
Beauty-From-Within Marketing: Best Practices and Pitfalls to Avoid
Nov 17, 2022
Interview
Danielle Masterson
‘Warning letter geek’ decodes marketing compliance
Asa Waldstein is principal of the Supplement Advisory Group and the man behind 'Warning Letter Wednesdays.' His bread and butter is educating companies about the dos and don'ts of marketing.
Oct 12, 2022
Press Mention
Maggie Jaqua
Regulatory and Enforcement Update on Notable Action in the Cognition, Adaptogen & Nootropic Space
Tune in to hear Asa Waldstein of the Supplement Advisory Group, a boutique group focusing on marketing risk analysis and practical marketing solutions for the web and social media, discuss the latest need-to-know regulatory information impacting the cognition, adaptogen, and nootropic space.
Oct 12, 2022
Guest Article
Asa Waldstein
Common Practitioner Pitfalls to Avoid When Marketing Dietary Supplements
Practitioners who sell supplements need to be aware that health and medical claims made in nutritional marketing can attract unwanted attention from the US Food and Drug Administration.
Sep 28, 2022
Guest Article
Asa Waldstein
Q3 warning letter roundup with Asa Waldstein
In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.
Aug 5, 2022
Press Mention
Rachel Adams
Compliance responsibilities when using a contract manufacturer
Brands need to ensure regulatory responsibilities are accounted for at the start of a contract manufacturing partnership.
Aug 1, 2022
Interview
Mychealla Rice
The Future of CBD research, marketing, and regulation
In this interview, Professor Ted Dinan, Medical Director at Atlantia Clinical Trials, and Asa Waldstein, Principal at Supplement Advisory Group, discuss Atlantia’s expertise in clinical trials for CBD
Jul 8, 2022
Interview
Sheldon Baker
Limiting Marketing Risk for Hemp and CBD Products
Asa Waldstein, principal at Supplement Advisory Group, advises companies on how to navigate murky waters in today's marketplace.
Jun 1, 2022
Press Mention
Josh Long
NDI warning letters fuel criticism of FDA enforcement approach—again
Former FDA officials and lawyers who advise clients on FDA regulations weigh in on a recent batch of warning letters targeting new dietary ingredients marketed in supplements.
May 3, 2022
Guest Article
Asa Waldstein
Compliance Essentials for Hemp-CBD Companies, Part 3 of 3: Marketing
May 3, 2022
Guest Article
Asa Waldstein
Q2 FDA warning letter roundup with Asa Waldstein
In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.
May 2, 2022
Press Mention, Data Mention
Isabella Davis
Mental Wellbeing in Today's Digital Age
Presentation
Apr 19, 2022
Interview
EU’s new THC limits for hemp-based products will ‘level the playing field’ for food producers
Asa and other industry leaders interviewed
